These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17462949)

  • 1. Yersinia outer proteins E, H, P, and T differentially target the cytoskeleton and inhibit phagocytic capacity of dendritic cells.
    Adkins I; Köberle M; Gröbner S; Bohn E; Autenrieth IB; Borgmann S
    Int J Med Microbiol; 2007 Jul; 297(4):235-44. PubMed ID: 17462949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell type-specific effects of Yersinia pseudotuberculosis virulence effectors.
    Fahlgren A; Westermark L; Akopyan K; Fällman M
    Cell Microbiol; 2009 Dec; 11(12):1750-67. PubMed ID: 19681909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yersinia enterocolitica can deliver Yop proteins into a wide range of cell types: development of a delivery system for heterologous proteins.
    Boyd AP; Grosdent N; Tötemeyer S; Geuijen C; Bleves S; Iriarte M; Lambermont I; Octave JN; Cornelis GR
    Eur J Cell Biol; 2000 Oct; 79(10):659-71. PubMed ID: 11089914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
    Viboud GI; Mejía E; Bliska JB
    Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis.
    Grosdent N; Maridonneau-Parini I; Sory MP; Cornelis GR
    Infect Immun; 2002 Aug; 70(8):4165-76. PubMed ID: 12117925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Rho GTPases and the actin cytoskeleton by Yersinia outer proteins (Yops).
    Aepfelbacher M; Heesemann J
    Int J Med Microbiol; 2001 Sep; 291(4):269-76. PubMed ID: 11680787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages.
    Zhang Y; Murtha J; Roberts MA; Siegel RM; Bliska JB
    Infect Immun; 2008 Sep; 76(9):4299-310. PubMed ID: 18591234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yersinia enterocolitica YopP inhibits MAP kinase-mediated antigen uptake in dendritic cells.
    Autenrieth SE; Soldanova I; Rösemann R; Gunst D; Zahir N; Kracht M; Ruckdeschel K; Wagner H; Borgmann S; Autenrieth IB
    Cell Microbiol; 2007 Feb; 9(2):425-37. PubMed ID: 16953801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity.
    Håkansson S; Schesser K; Persson C; Galyov EE; Rosqvist R; Homblé F; Wolf-Watz H
    EMBO J; 1996 Nov; 15(21):5812-23. PubMed ID: 8918459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
    Monnazzi LG; Carlos IZ; de Medeiros BM
    Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.
    Logsdon LK; Mecsas J
    Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinate involvement of invasin and Yop proteins in a Yersinia pseudotuberculosis-specific class I-restricted cytotoxic T cell-mediated response.
    Falgarone G; Blanchard HS; Virecoulon F; Simonet M; Breban M
    J Immunol; 1999 Mar; 162(5):2875-83. PubMed ID: 10072536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
    Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
    Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of target cell adhesion structures by the Yersinia effector YopH requires interaction with the substrate domain of p130Cas.
    Mogemark L; McGee K; Yuan M; Deleuil F; Fällman M
    Eur J Cell Biol; 2005 Apr; 84(4):477-89. PubMed ID: 15900707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular mechanisms of bacterial internalization counteracted by Yersinia.
    Fällman M; Gustavsson A
    Int Rev Cytol; 2005; 246():135-88. PubMed ID: 16164968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues.
    Logsdon LK; Mecsas J
    Infect Immun; 2003 Aug; 71(8):4595-607. PubMed ID: 12874339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of IFN-gamma and IL-6 in a protective immune response to Yersinia enterocolitica in mice.
    Matteoli G; Fahl E; Warnke P; Müller S; Bonin M; Autenrieth IB; Bohn E
    BMC Microbiol; 2008 Sep; 8():153. PubMed ID: 18803824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YopT, a new Yersinia Yop effector protein, affects the cytoskeleton of host cells.
    Iriarte M; Cornelis GR
    Mol Microbiol; 1998 Aug; 29(3):915-29. PubMed ID: 9723929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Destabilization of YopE by the ubiquitin-proteasome pathway fine-tunes Yop delivery into host cells and facilitates systemic spread of Yersinia enterocolitica in host lymphoid tissue.
    Gaus K; Hentschke M; Czymmeck N; Novikova L; Trülzsch K; Valentin-Weigand P; Aepfelbacher M; Ruckdeschel K
    Infect Immun; 2011 Mar; 79(3):1166-75. PubMed ID: 21149597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Yersinia Yop virulon, a bacterial system to subvert cells of the primary host defense.
    Cornelis GR
    Folia Microbiol (Praha); 1998; 43(3):253-61. PubMed ID: 9717252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.